Growth Metrics

KalVista Pharmaceuticals (KALV) Shares Outstanding: 2014-2024

Historic Shares Outstanding for KalVista Pharmaceuticals (KALV) over the last 5 years, with Dec 2024 value amounting to $49.4 million.

  • KalVista Pharmaceuticals' Shares Outstanding was N/A to $49.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $49.4 million, marking a year-over-year change of. This contributed to the annual value of $42.5 million for FY2024, which is N/A change from last year.
  • KalVista Pharmaceuticals' Shares Outstanding amounted to $49.4 million in Q4 2024, which was up 14.24% from $43.3 million recorded in Q4 2024.
  • In the past 5 years, KalVista Pharmaceuticals' Shares Outstanding ranged from a high of $49.4 million in Q4 2024 and a low of $17.8 million during Q1 2020.
  • Its 2-year average for Shares Outstanding is $40.2 million, with a median of $42.5 million in 2024.
  • Data for KalVista Pharmaceuticals' Shares Outstanding shows a peak YoY increased of 25.73% (in 2024) over the last 5 years.
  • Over the past 4 years, KalVista Pharmaceuticals' Shares Outstanding (Quarterly) stood at $17.9 million in 2020, then increased by 0.98% to $18.0 million in 2021, then reached $34.4 million in 2023, then grew by 25.71% to $49.4 million in 2024.
  • Its Shares Outstanding was $49.4 million in Q4 2024, compared to $43.3 million in Q4 2024 and $43.1 million in Q3 2024.